Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-inflammatory agent 102

Product Specifications

CAS Number

3053104-47-2

Target

MAP3K, MAPK, NF-κB, p38 MAPK, Reactive Oxygen Species, Interleukin, NO Synthase

Related Pathways

Immunology/Inflammation, NF-κB, MAPK, Metabolism

Bioactivity

Anti-inflammatory agent 102 (Compound 11a) is an orally effective anti-inflammatory compound. It exerts its effects by inhibiting the activation of the ASK1/p38 MAPKs/NF-κB signaling pathway. This agent displays significant anti-inflammatory activity by suppressing the release of NO, ROS, and inflammatory cytokines such as IL-6, TNF-α, and IL-1β. Anti-inflammatory agent 102 is applicable in research concerning inflammatory diseases, including ulcerative colitis (UC) .

Smiles

O=C1N(C2=NC=CC=C2)CCN1C3=CC(Cl)=C(OC)C=C3OC

Molecular Formula

C16H16ClN3O3

Molecular Weight

333.77

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Recombinant Cystatin A Monoclonal Antibody
AN301505L-01 50 µL

Recombinant Cystatin A Monoclonal Antibody

Sign In for Pricing
View Details
Recombinant Cystatin A Monoclonal Antibody
AN301505L-02 100 µL

Recombinant Cystatin A Monoclonal Antibody

Sign In for Pricing
View Details
CD33 Recombinant Rabbit monoclonal Antibody
HA750814 100 µL

CD33 Recombinant Rabbit monoclonal Antibody

Sign In for Pricing
View Details
UBAC2 (NM_001144072) Human Over-expression Lysate
LY428495 100 µg

UBAC2 (NM_001144072) Human Over-expression Lysate

Sign In for Pricing
View Details
Cytokeratin 3 (KRT3) (Corneal Epithelial Marker) (KRT3/2130), CF568 conjugate, 0.1mg/mL
BNC682130-100 1x 100 µL

Cytokeratin 3 (KRT3) (Corneal Epithelial Marker) (KRT3/2130), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Tissue FFPE Sections, Kidney
CS808189 5x 5 µm

Tissue FFPE Sections, Kidney

Sign In for Pricing
View Details